{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T10:57:49Z","timestamp":1790506669991,"version":"4.1.0"},"reference-count":26,"publisher":"European Respiratory Society (ERS)","issue":"5","funder":[{"name":"TEVA Pharmaceuticals Europe B.V."}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir J"],"accepted":{"date-parts":[[2017,3,27]]},"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1183\/13993003.00634-2017","type":"journal-article","created":{"date-parts":[[2017,5,2]],"date-time":"2017-05-02T00:40:33Z","timestamp":1493685633000},"page":"1700634","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":163,"title":["Severe eosinophilic asthma: a roadmap to\u00a0consensus"],"prefix":"10.1183","volume":"49","author":[{"given":"Roland","family":"Buhl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Humbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leif","family":"Bjermer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Chanez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liam\u00a0G.","family":"Heaney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Pavord","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"Quirce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johann C.","family":"Virchow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Holgate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2017,5,1]]},"reference":[{"key":"2024101903550663000_49.5.1700634.1","first-page":"243","article-title":"Asthma phenotypes and endotypes: an evolving paradigm for classification","volume":"15","author":"Corren","year":"2013","journal-title":"Discov Med"},{"key":"2024101903550663000_49.5.1700634.2","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01359-2015"},{"key":"2024101903550663000_49.5.1700634.3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00157-9"},{"key":"2024101903550663000_49.5.1700634.4","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00202013"},{"key":"2024101903550663000_49.5.1700634.5","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00024-2015"},{"key":"2024101903550663000_49.5.1700634.6","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(16)31537-9","article-title":"Treatment for severe eosinophilic asthma-consistent effect of anti-interleukin-5 antibodies?","volume":"388","author":"Castro","year":"2016","journal-title":"Lancet"},{"key":"2024101903550663000_49.5.1700634.7","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00201813"},{"key":"2024101903550663000_49.5.1700634.8","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/S0140-6736(16)31324-1","article-title":"Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting \u03b22-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial","volume":"388","author":"Bleecker","year":"2016","journal-title":"Lancet"},{"key":"2024101903550663000_49.5.1700634.9","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(15)00042-9"},{"key":"2024101903550663000_49.5.1700634.10","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(16)30031-5"},{"key":"2024101903550663000_49.5.1700634.11","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60988-X"},{"key":"2024101903550663000_49.5.1700634.12","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/S0140-6736(16)31322-8","article-title":"Benralizumab, an anti-interleukin-5 receptor \u03b1 monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial","volume":"388","author":"FitzGerald","year":"2016","journal-title":"Lancet"},{"key":"2024101903550663000_49.5.1700634.13","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1056\/NEJMoa1403291","article-title":"Glucocorticoids and mepolizumab in eosinophilic asthma","volume":"371","author":"Bel","year":"2014","journal-title":"N Engl J Med"},{"key":"2024101903550663000_49.5.1700634.14","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.chest.2016.03.018","article-title":"Phase 3 study of reslizumab in patients with poorly controlled asthma: effects across a broad range of eosinophil counts","volume":"150","author":"Corren","year":"2016","journal-title":"Chest"},{"key":"2024101903550663000_49.5.1700634.15","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.chest.2016.03.032","article-title":"Reslizumab for inadequately controlled asthma with elevated blood eosinophil levels: a randomized phase 3 study","volume":"150","author":"Bjermer","year":"2016","journal-title":"Chest"},{"key":"2024101903550663000_49.5.1700634.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2014.08.042"},{"key":"2024101903550663000_49.5.1700634.17","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00100-2015"},{"key":"2024101903550663000_49.5.1700634.18","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200711-1754OC"},{"key":"2024101903550663000_49.5.1700634.19","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(15)00367-7"},{"key":"2024101903550663000_49.5.1700634.20","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.jaci.2012.06.040","article-title":"Do all asthmatics with atopy have atopic asthma?","volume":"130","author":"Arbes","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"2024101903550663000_49.5.1700634.21","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2014-205634"},{"key":"2024101903550663000_49.5.1700634.22","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(14)70201-2"},{"key":"2024101903550663000_49.5.1700634.23","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01824-2014"},{"key":"2024101903550663000_49.5.1700634.24","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/cea.12862","article-title":"Individually dosed omalizumab: an effective treatment for severe peanut allergy","volume":"47","author":"Brandstr\u00f6m","year":"2017","journal-title":"Clin Exp Allergy"},{"key":"2024101903550663000_49.5.1700634.25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3038.2011.01260.x"},{"key":"2024101903550663000_49.5.1700634.26","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/cea.12853","article-title":"Comparison of anti-interleukin-5 therapies in patients with severe asthma: global and indirect meta-analyses of randomized placebo-controlled trials","volume":"47","author":"Cabon","year":"2017","journal-title":"Clin Exp Allergy"}],"container-title":["European Respiratory Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/13993003.00634-2017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T06:40:41Z","timestamp":1740379241000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/13993003.00634-2017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":26,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2017,5,1]]},"published-print":{"date-parts":[[2017,5]]}},"alternative-id":["10.1183\/13993003.00634-2017"],"URL":"https:\/\/doi.org\/10.1183\/13993003.00634-2017","relation":{},"ISSN":["0903-1936","1399-3003"],"issn-type":[{"value":"0903-1936","type":"print"},{"value":"1399-3003","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5]]}}}